Retraction Note: Combined treatment of glibenclamide and CoCl2 decreases MMP9 expression and inhibits growth in highly metastatic breast cancer

Saved in:
Bibliographic Details
Main Authors: Zhe Rong, Li Li, Fei Fei, Lailong Luo, Yang Qu
Format: Article
Language:English
Published: BMC 2025-02-01
Series:Journal of Experimental & Clinical Cancer Research
Online Access:https://doi.org/10.1186/s13046-025-03311-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823861509384568832
author Zhe Rong
Li Li
Fei Fei
Lailong Luo
Yang Qu
author_facet Zhe Rong
Li Li
Fei Fei
Lailong Luo
Yang Qu
author_sort Zhe Rong
collection DOAJ
format Article
id doaj-art-db390a0bdfa04d51aec2f4c52fce65a8
institution Kabale University
issn 1756-9966
language English
publishDate 2025-02-01
publisher BMC
record_format Article
series Journal of Experimental & Clinical Cancer Research
spelling doaj-art-db390a0bdfa04d51aec2f4c52fce65a82025-02-09T12:59:53ZengBMCJournal of Experimental & Clinical Cancer Research1756-99662025-02-014411110.1186/s13046-025-03311-zRetraction Note: Combined treatment of glibenclamide and CoCl2 decreases MMP9 expression and inhibits growth in highly metastatic breast cancerZhe Rong0Li Li1Fei Fei2Lailong Luo3Yang Qu4Department of Basic Medicine & Experimental Technology, Division of Clinical Medicine, Logistic University of Chinese People’s Armed Police ForceDepartment of Pathology, Anhui Medical UniversityDepartment of Pathology, Anhui Medical UniversityDepartment of Pathology, Anhui Medical UniversityDepartment of Neurosurgery, Logistic University Affiliated Hospital, Logistic University of Chinese People’s Armed Police Forcehttps://doi.org/10.1186/s13046-025-03311-z
spellingShingle Zhe Rong
Li Li
Fei Fei
Lailong Luo
Yang Qu
Retraction Note: Combined treatment of glibenclamide and CoCl2 decreases MMP9 expression and inhibits growth in highly metastatic breast cancer
Journal of Experimental & Clinical Cancer Research
title Retraction Note: Combined treatment of glibenclamide and CoCl2 decreases MMP9 expression and inhibits growth in highly metastatic breast cancer
title_full Retraction Note: Combined treatment of glibenclamide and CoCl2 decreases MMP9 expression and inhibits growth in highly metastatic breast cancer
title_fullStr Retraction Note: Combined treatment of glibenclamide and CoCl2 decreases MMP9 expression and inhibits growth in highly metastatic breast cancer
title_full_unstemmed Retraction Note: Combined treatment of glibenclamide and CoCl2 decreases MMP9 expression and inhibits growth in highly metastatic breast cancer
title_short Retraction Note: Combined treatment of glibenclamide and CoCl2 decreases MMP9 expression and inhibits growth in highly metastatic breast cancer
title_sort retraction note combined treatment of glibenclamide and cocl2 decreases mmp9 expression and inhibits growth in highly metastatic breast cancer
url https://doi.org/10.1186/s13046-025-03311-z
work_keys_str_mv AT zherong retractionnotecombinedtreatmentofglibenclamideandcocl2decreasesmmp9expressionandinhibitsgrowthinhighlymetastaticbreastcancer
AT lili retractionnotecombinedtreatmentofglibenclamideandcocl2decreasesmmp9expressionandinhibitsgrowthinhighlymetastaticbreastcancer
AT feifei retractionnotecombinedtreatmentofglibenclamideandcocl2decreasesmmp9expressionandinhibitsgrowthinhighlymetastaticbreastcancer
AT lailongluo retractionnotecombinedtreatmentofglibenclamideandcocl2decreasesmmp9expressionandinhibitsgrowthinhighlymetastaticbreastcancer
AT yangqu retractionnotecombinedtreatmentofglibenclamideandcocl2decreasesmmp9expressionandinhibitsgrowthinhighlymetastaticbreastcancer